Amneal Pharmaceuticals, Inc. (AMRX) Depreciation USD 2016 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Amneal Pharmaceuticals, Inc. annual/quarterly Depreciation history and growth rate from 2016 to 2023.
  • Amneal Pharmaceuticals, Inc. Depreciation for the quarter ending September 30, 2018 was $17.4 M, a 62.5% increase year-over-year.
  • Amneal Pharmaceuticals, Inc. annual Depreciation for 2023 was $66.2 M, a 2.79% decline from 2022.
  • Amneal Pharmaceuticals, Inc. annual Depreciation for 2022 was $68.1 M, a 12.2% increase from 2021.
  • Amneal Pharmaceuticals, Inc. annual Depreciation for 2021 was $60.7 M, a 0.46% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $66.2 M -$1.9 M -2.79% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $68.1 M +$7.4 M +12.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $60.7 M +$280 K +0.46% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 $60.4 M -$2.86 M -4.52% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-03
2019 $63.3 M -$1.13 M -1.76% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $64.4 M +$22.5 M +53.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $42 M +$12.6 M +43.1% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $29.3 M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.